This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 115/4/475    most recent CIRCULATIONAHA.106.644609v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vanhoutte, D. Articles by Heymans, S. Search for Related Content PubMed PubMed Citation Articles by Vanhoutte, D. Articles by Heymans, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Cardiomyopathy Heart Attack Related Collections Animal models of human disease Heart failure - basic studies Acute myocardial infarction Gene therapy

(Circulation. 2007;115:475-482.)
© 2007 American Heart Association, Inc.

Heart Failure

Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction

Davy Vanhoutte, MS^*; Mark W.M. Schellings, MS^*; Martin Götte, MS, PhD; Melissa Swinnen, MS; Veronica Herias, PhD; Martin K. Wild, PhD; Dietmar Vestweber, PhD; Emmanuel Chorianopoulos, MD, PhD; Víctor Cortés, MS; Attilio Rigotti, MD, PhD; Mary-Ann Stepp, PhD; Frans Van de Werf, MD, PhD; Peter Carmeliet, MD, PhD; Yigal M. Pinto, MD, PhD; Stephane Heymans, MD, PhD

From Experimental and Molecular Cardiology/CARIM, University of Maastricht, Maastricht, the Netherlands (M.W.M.S., M.S., V.H., Y.M.P., S.H.); Molecular and Vascular Biology and Center for Transgene Technology and Gene Therapy, VIB (D. Vanhoutte, E.C., P.C.) and Department of Cardiology (F.V.d.W.), University of Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, Muenster University Hospital, Muenster, Germany (M.G.); Max Planck Institute for Molecular Biomedicine, c/o Institute of Cell Biology, ZMBE, Muenster, Germany (M.K.W., D. Vestweber); Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica, Marcoleta, Santiago, Chile (V.C., A.R.); and George Washington University Medical Center, Washington, DC (M.-A.S.).

Correspondence to Stephane Heymans, MD, PhD, Experimental and Molecular Cardiology/CARIM, Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail s.heymans{at}cardio.unimaas.nl

Received June 8, 2006; accepted November 20, 2006.

Background— The cell-associated proteoglycan syndecan-1 (Synd1) closely regulates inflammation and cell-matrix interactions during wound healing and tumorigenesis. The present study investigated whether Synd1 may also regulate cardiac inflammation, matrix remodeling, and function after myocardial infarction (MI).

Methods and Results— First, we showed increased protein and mRNA expression of Synd1 from 24 hours on, reaching its maximum at 7 days after MI and declining thereafter. Targeted deletion of Synd1 resulted in increased inflammation and accelerated, yet functionally adverse, infarct healing after MI. In concordance, adenoviral gene expression of Synd1 protected against exaggerated inflammation after MI, mainly by reducing transendothelial adhesion and migration of leukocytes, as shown in vitro. Increased inflammation in the absence of Synd1 resulted in increased monocyte chemoattractant protein-1 expression, increased activity of matrix metalloproteinase-2 and -9, and decreased activity of tissue transglutaminase, associated with increased collagen fragmentation and disorganization. Exaggerated inflammation and adverse matrix remodeling in the absence of Synd1 increased cardiac dilatation and impaired systolic function, whereas gene overexpression of Synd1 reduced inflammation and protected against cardiac dilatation and failure.

Conclusions— Increased expression of Synd1 in the infarct protects against exaggerated inflammation and adverse infarct healing, thereby reducing cardiac dilatation and dysfunction after MI in mice.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M. Gotte, D. Spillmann, G. W. Yip, E. Versteeg, F. G. Echtermeyer, T. H. van Kuppevelt, and L. Kiesel Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (ss4GalT-7) deficient form of Ehlers-Danlos syndrome Hum. Mol. Genet., April 1, 2008; 17(7): 996 - 1009. [Abstract] [Full Text] [PDF]

				D. Vanhoutte and S. Heymans Factor XIII: the cement of the heart after myocardial infarction? Eur. Heart J., February 2, 2008; 29(4): 427 - 428. [Full Text] [PDF]

				M. A. Stepp, Y. Liu, S. Pal-Ghosh, R. A. Jurjus, G. Tadvalkar, A. Sekaran, K. LoSicco, L. Jiang, M. Larsen, L. Li, et al. Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1 J. Cell Sci., August 15, 2007; 120(16): 2851 - 2863. [Abstract] [Full Text] [PDF]